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There is an increasing amount of evidence that oxidative stress related 
to hypertension can damage the function of diverse structures such as aorta. It 
is a well-established fact that chlorogenic acid and anthocyanine found in 
purple sweet potato generates bioactive compound with antihypertensive and 
antioxidant activities. The present study sought to investigate antioxidant 
activity of extract ethanol of purple sweet potato (EP) in deoxycorticosterone 
acetate (DOCA–salt)–induced hypertensive rats (Rattus norvegicus). The rats 
were orally administrated a 95% ethanol extract of purple sweet potato (var. 
Ayamurasaki) (EP) in a daily dose of 200 and 400 mg/kg body weight for 4 
weeks. Aorta total malondialdehyde (MDA) and histopathology of aorta 
abdominal were examined. Aorta injury was observed in DOCA-salt 
hypertensive group rats compared to normotensive group rats, as aorta MDA 
significantly increased  (P<0.05). In contrast, treatment of DOCA-salt 
hypertensive rats with different dose of EP significantly reduced the total aorta 
MDA, as well as repair kidney damage, suppressed smooth muscle cell 
proliferation and lessen aorta wall thickening compared to controls. This is the 
first report that demonstrated blood pressure lowering and antioxidative effects 
of an ethanol extract of purple sweet potato, containing chlorogenic acid, in a 
DOCA–salt model of hypertension. 
 
 
 
Introduction 
Hypertension is a major cause of mortality 
associated with cardiovascular disease, cerebrovascular 
disease, and renal disease. It has a prevalence of 26.4% 
in the adult population, totaling nearly one billion 
individuals, and it has been estimated that it will increase 
up to 29% (1.5 billion) by the year 2025 (Rubattu et al., 
2015). The renin-angiotensin-aldosterone system 
(RAAS) is a hormonal cascade that has various functions 
in the pathogenesis of cardiovascular diseases. 
Angiotensin-II, a potent vasoconstrictor, is the primary 
active product of the RAAS that plays a central role in the 
development of hypertension (Atlas, 2007). 
Hypertension also has been associated with stress 
oxidation, which results from an imbalance between the 
production of reactive oxygen species (ROS) and the 
antioxidant defense system (Vaziri, 2008). In this case, 
ROS production by NADPH oxidase is increased, 
causing vascular disease and dysfunction. ROS 
production in other organs, particularly the kidney, likely 
contributes to blood pressure regulation (Harrison et al., 
2007). The DOCA-salt–induced rat model is an 
endocrine hypertension model that progresses quickly to 
severe hypertension and oxidative stress (Dornas and 
Silva, 2011), allowing an understanding of progression of 
the disease and testing of potential therapies, such as, 
here, the potential use of ethanol extract of purple sweet 
potato, containing chlorogenic acid as the therapeutic 
agent. 
Purple sweet potato is known to have several 
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advantages over other sweet potatoes in terms of 
potential hypertension reduction. It contains 
anthocyanins, dioscorin protein, and chlorogenic acid, 
which has been noted to have antihypertensive. 
Chlorogenic acid can inhibit the angiotensin converting 
enzyme (ACE), which has an important role in converting 
angiotensin-I to angiotensin-II by blocking the active site 
of the enzyme (Yashimoto et al., 1999). Angiotensin-II is 
both a potent vasoconstrictor and stimulator for the 
synthesis and release of aldosterone, which 
subsequently increases blood pressure by promoting 
sodium retention in the distal tubules (Ferrario, 2010). 
Given the above considerations, the inhibition of ACE 
could be useful in the treatment of hypertension (Ramos-
Nino and Blumen, 2009).  
Hence, administration of pirple sweet potato 
extract is considered a useful therapeutic approach in the 
treatment of high blood pressure. To understand dose-
dependent effects of ethanol extract of purple sweet 
potato–derived chlorogenic acid treatment on MDA level,  
and aorta hispathology, we used DOCA-salt–induced 
hypertension Wistar rat (Rattus norvegicus) strains as an 
animal model. The current study demonstrated a 
decrease in MDA (Malonaldehyde) and an recovery of 
histological changes after a single oral administration of 
purple sweet potato ethanol extract in DOCA-salt–
induced hypertension rats. 
 
Materials and Methods 
This research used purple sweet potatoes var. 
Ayamurasaki; 95% ethanol; deoxycorticosterone acetate 
(DOCA) (Sigma, Pcode 1001376001, USA); NaCl; corn 
oil (Sigma, Pcode 1000925370 C8726-500 ml). 
 
Animal model 
All procedures were carried out in accordance with 
conventional guidelines for experimentation with 
animals. Twelve-week-old male Wistar rat (R. 
norvegicus) strains were used. The rats were divided into 
five groups, i.e., normotensive (NTN) (A); hypertensive 
(HTN) (B), HTN + ethanol extract (EP) at one-half 
standard dose (200 mg/kg) b/w (C); HTN + EP  
standard dose of 400 mg/kg b/w (D), and were housed 
in groups of five per cage, as a number for replication,  
in a regulated environment with a 12 h light/dark cycle. 
Hypertensive rats were prepared by induction of 
deoxycorticosterone acetate (DOCA), twice a week for 
five weeks (10 injections). For administration, DOCA was 
dissolved in 0.5 ml corn oil (Badyal et al., 2003; Khorsid 
et al., 2012). DOCA was injected subcutaneously in the 
cervical spine with the first five doses being 20 mg/kg, 
and the last five doses 10 mg/kg. Rats were administered 
1% NaCl via their drinking water. Rats in groups C and 
D,E received, by oral administration, using a canula, a 
daily dose of EP at either 200 or 400 mg/kg body weight,  
respectively, dissolved in reverse osmosis water, for 4 
consecutive weeks. The control group received a normal 
diet. 
 
Preparation of purple sweet potato ethanol extract (EP) 
Purple sweet potatoes were sorted and weighed 
then washed with clean water. After that, the sweet 
potatoes were sliced into small pieces and blended with 
95% ethanol at a ratio of 1:8 (v/v) potato: ethanol for the 
30s. The suspension was then screened and macerated 
for 2 x 12 hours. After that, the solution was filtered again 
by vacuum screening and Whatman paper@ until getting 
the filtrate for evaporating and their residue extracting 
again until 4 times, which was used for the further 
experiments.  
 
Malondialdehyde (MDA) level  
Malondialdehyde (MDA) level which is a marker 
of lipid peroxidation was measured using the TBA 
reaction method in kidney and aorta tissue 
homogenates  from treated and untreated DOCA-salt 
rats and normotensive rats using a prior adopted 
method. 
 
Histopathology of kidney and abdominal aorta 
All rats were deeply anesthetized with 
Chloroform 10%. Abdominal aorta were fixed in cold 
10% buffered formalin, the tissues were then 
transversally trimmed and submitted to a routine 
process for paraffin embedding. The abdominal aorta  
sections were prepared, deparaffinised, and stained 
with haematoxylin and eosin (H&E) for histology 
analysis. 
 
Statistical Analysis 
The results of MDA were expressed as means ± 
standard deviation (SD). Differences between trial 
groups were statistically analysed using analysis of 
variance (ANOVA), followed by the post hoc Tukey test 
for determining significant difference at p < 0.05. 
 
Table 1. Effect of extract ethanol purple sweet potato (EP) on 
the levels of Malondialdehyde (MDA) in abdominal aorta of 
DOCA-salt hypertensive rats (mean±SD) (n=4) 
Groups MDA 
Level(µg/ml) 
 
Increase in 
MDA level 
(%) 
Reduce in MDA 
level (%) 
 
Normotensive 
(NTN) 
2.32±0.28a - - 
Hypertensive 
(HTN) 
6.02±0.19b 159.48 - 
HTN + EP 200 3.69±0.11a - 38.71 
HTN + EP 400 2.60±0,18a - 56.81 
Note: Values not sharing a common superscript differ significantly at 
P<0.05. *EP: Extract ethanol of Purple Sweet Potato; CA: Chlorogenic 
Acid 
 
Results and Discussion 
Effect of extract ethanol of purple sweet potato 
The serum levels of MDA as the markers of 
oxidative stress in abdominal aorta of the normotensive 
(NTN), the hypertensive (HTN) and  the casein - treated 
hypertensive rats  were shown in Table 1. Induction of 
normotensive rats with DOCA-salt for 4 weeks resulted 
in increased of MDA level. The MDA level of DOCA-salt 
hypertensive rats was significantly differ (P<0.05) 
compared to normotensive rats. There was considerably 
increased of MDA up to 159.4 % in abdominal aorta of 
DOCA- salt hypertensive rats. These finding was   
evidence of aorta damages related to stress oxidative, 
thus indicating an increase in the oxidative stress levels 
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in the hypertensive rats as compared to those in the 
normotensive group. Elevation of blood pressure in the 
DOCA-salt model may activate oxidative stress through 
an unregulated NADPH oxidase. Oral administration of 
200 and 400 mg/kg bw of EP for a period of four 
consecutive weeks to the hypertensive rats significantly 
reduced MDA level (p<0.05). However, there was 
significant different effect of  the dose of EP to the 
aorta MDA level of the treated hypertensive rats. 
Eventhough, EP at the dose of 400 mg/kg bw gave better 
effect in reducing aorta MDA level (56.81%)  as  
compared  to  the  dose  of  200  mg/kg  bw  
(38.71%).  Several  studies  have  reported the 
antioxidative activity of food peptides. To our knowledge, 
this is the first study reporting the extract ethanol of 
purple sweet potato (EP) with antioxidative activity that 
may reduce the effect of oxidative stress in DOCA-salt 
hypertensive rats. This study also demonstrated that 
bringing of the blood pressure to the normotensive state 
using  EP containing bioactive compound not only 
decreased the blood pressure but that also attenuated 
organ damages. 
 
 
Figure 1.Histopathological changes in the aorta (HE, 40x). 
Normotensive-rat Aorta (A);  DOCA-salt hypertensive (HTN) 
aorta (B); HTN + EP (200 mg/kg bw) treated aorta(C); HTN + 
EP (400 mg/kg bw) treated aorta(D); (EC) Endotel cell; (SC) 
Smooth Muscle cell; (SCn) Necrotic Smooth Muscle cell; (TI) 
Tunica Intima; (TM) Tunica Media; (TA) Tunica Adventitia. 
EP=ethanol extract purple sweet potato; CA =chlorogenic acid 
 
Histopathology of aorta abdominal 
Histological analysis of the aorta abdominal in 
normotensive rats was showing normal glomeruli and 
tubules, and  histopathological changes  was 
observed in the architecture of  aorta abdominal of all 
DOCA-salt hypertensive  group (Figure 1). 
Hypertension is associated with structural and 
functional alterations of blood vessels. Figure  revealed 
that the aorta abnominal of normotensive rats (A) 
showed no histological changes, while in the 
hypertensive rats (B), there were thickening of tunica 
media (TM) and alteration of tunica intima (TI), increased 
numbers of smooth muscle cells (S) as well as the 
evidence of necrotic smooth muscle cells (Sa). 
Disruption of tunica intima, marked hypertrophy and 
thickening with proliferation of myocytes in tunica media 
was reported in histological studies with rats submitted 
to DOCA-salt hypertension. The tunica media thickness 
(TM) and amount of necrotic smooth muscle cells (Sa) 
were substantially changed by administration of EP for 
4 weeks, in the present study (Fig 1C and 1D). These 
finding suggested a significant effect of this treatment  
on the development of hypertension. Although  many 
evidence clearly indicated the antioxidative activity of 
EP, few study had evaluated the antioxidant effects 
exerted by extract ethanol of purple sweet potato (EP)  
in DOCA-salt hypertensive model. 
 
Conclusion 
Assessment of the antihypertension and 
antioxidative  properties of extract ethanol of purple 
sweet potato (EP)  in the present study showed a 
significant effect in attenuating  abdominal aorta 
damages in DOCA-salt hypertensive model. These 
findings have suggested that the extract ethanol of 
purple sweet potato (EP) with high bioactive content 
like chlorogenic acid and anthocyanin might be 
considered  as potential antihypertension and 
antioxidants that resistant to digestive proteases.  
However, further investigation is needed to evaluate 
bioavailability and efficacy of an purple sweet potato 
(EP) after GI digestion, which was significant for the 
preparation of nutraceutical food component. 
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